NCT03888664View on ClinicalTrials.gov

Open Trail of γIFN for Friedreich Ataxia

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 26, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Friedreich Ataxia
Interventions
DRUG

gamma interferon

1st two weeks: gIFN 100 ugr/three times a week from the 3rd week: gIFN 200 ugr/ three times a week for the following 22 weeks From the 25th week: no treatment for the following 24 weeks

All Listed Sponsors
lead

IRCCS Eugenio Medea

OTHER

NCT03888664 - Open Trail of γIFN for Friedreich Ataxia | Biotech Hunter | Biotech Hunter